Are you Dr. Kulkarni?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 26 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1025 Regent St
Madison, WI 53715Phone+1 608-282-2000Fax+1 608-282-2172
Summary
- Dr. Amol Kulkarni, MD is a board certified ophthalmologist in Madison, Wisconsin. He is currently licensed to practice medicine in Wisconsin.
Education & Training
University of Wisconsin Hospitals and ClinicsResidency, Ophthalmology, 2008 - 2011
Ascension Illinois/Saint FrancisInternship, Internal Medicine, 2007 - 2008
Seth G.S. Medical CollegeClass of 2000
Certifications & Licensure
WI State Medical License 2006 - 2025- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Publications & Presentations
PubMed
- 139 citationsResveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria.Paul R. van Ginkel, Dhruv Sareen, Lalita Subramanian, Quintisha Walker, Soesiawati R. Darjatmoko
Clinical Cancer Research. 2007-09-01 - 65 citationsOcular changes after photodynamic therapy.Radouil Tzekov, Ton Lin, Kai-Ming Zhang, Brittany A. Jackson, A. Oyejide
Investigative Ophthalmology & Visual Science. 2006-01-01 - 18 citationsUse of Combination Therapy with Cisplatin and Calcitriol in the Treatment of Y-79 Human Retinoblastoma Xenograft ModelAmol D. Kulkarni, P.R. van Ginkel, Soesiawati R. Darjatmoko, Mary J. Lindstrom, Daniel M. Albert
The British Journal of Ophthalmology. 2009-08-01
Press Mentions
Scientist Develop Inexpensive Technology for Production of Silver NanowiresFebruary 2nd, 2020
